Chunghwa Chemical Synthesis & Biotech Co Ltd banner
C

Chunghwa Chemical Synthesis & Biotech Co Ltd
TWSE:1762

Watchlist Manager
Chunghwa Chemical Synthesis & Biotech Co Ltd
TWSE:1762
Watchlist
Price: 29.45 TWD -1.83% Market Closed
Market Cap: NT$2.3B

Wall Street
Price Targets

Price Targets Summary
Chunghwa Chemical Synthesis & Biotech Co Ltd

There are no price targets for Chunghwa Chemical Synthesis & Biotech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Chunghwa Chemical Synthesis & Biotech Co Ltd Competitors:
Price Targets
CCOI
Cogent Communications Holdings Inc
37% Upside

Revenue
Forecast

1% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
1% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 13 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's revenue is 1%. The projected CAGR for the next 2 years is 3%.

Operating Income
Forecast

-22% / Year
Past Growth
123% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
-22% / Year
Past Growth
123% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

For the last 13 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's operating income is -22%. The projected CAGR for the next 2 years is 123%.

Net Income
Forecast

-9% / Year
Past Growth
-18% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
-9% / Year
Past Growth
-18% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 13 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's net income is -9%. The projected CAGR for the next 2 years is -18%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Chunghwa Chemical Synthesis & Biotech Co Ltd's stock price target?
Not Available

Chunghwa Chemical Synthesis & Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Chunghwa Chemical Synthesis & Biotech Co Ltd's Revenue forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's revenue is 1%. The projected CAGR for the next 2 years is 3%.

What is Chunghwa Chemical Synthesis & Biotech Co Ltd's Operating Income forecast?
Projected CAGR
123%

For the last 13 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's operating income is -22%. The projected CAGR for the next 2 years is 123%.

What is Chunghwa Chemical Synthesis & Biotech Co Ltd's Net Income forecast?
Projected CAGR
-18%

For the last 13 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's net income is -9%. The projected CAGR for the next 2 years is -18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett